PhD Completion Seminar - Daniel Perkins
Share via
Title: Mental Health and Wellbeing Outcomes Associated with the Naturalistic Use of DMT-Harmala Alkaloid Preparations
Supervisors: Prof Richard Chenhall, Centre for Health Equity, Melbourne School of Population and Global Health; Prof Robin Room, Melbourne School of Population and Global Health.
Abstract: This thesis utilised two non-probability observational studies in naturalistic settings to evaluate associations between the use of DMT-harmala preparations, containing the psychedelic compound DMT and harmala alkaloids, and mental health outcomes. Findings indicate that consumption is associated with positive mental health and wellbeing effects, lower alcohol and drug use, and beneficial life and lifestyle change. Certain demographic and contextual factors, as well as aspects of the acute experience, were found to positively or negatively influence these outcomes.
Bio: Dr Daniel Perkins is a Senior Research Fellow in the School of Population and Global Health, where he is also undertaking a second PhD. His research investigates the therapeutic application of medicinal cannabis and psychedelic substances including ayahuasca. He is involved in various medicinal psychedelics research studies, including as a CI on an NHMRC-MRRF funded clinical trial investigating the use of a DMT-harmala drug product for depression and alcohol use disorder.
Date: Monday 30 September at 12pm
Venue: Seminar Room 410, Level 4, 207 Bouverie Street, Carlton
Zoom link: https://go.unimelb.edu.au/fe78